Apparently getting on the FDA list for potentially acceptable labs to process the COVID test is a reasonably big deal. Besides ARYC’S CLIA certified lab - hope the license was renewed - there are only a dozen or so other labs.
What is holding back ARYC’S stock price from popping is FDA acceptance of their microarray based COVID test!!!
Unfortunately this could take a long time as criticism of the FDA mounts because they allowed fake tests to be plied while the certification process continues.
The FDA could clamp down any day now on sale of uncertified COVID tests like ARYC’S test!!!
Market Data 
Markets 
AI
